Analysis of the two data sets, Taylor Prostate 3 and Grasso Prostate, revealed a trend towards poor prognoses, including reduced recurrence-free and overall survival time in PCa patients with high SREBP-2 expression compared to the low SREBP-2 expression group (Figure 1D; Supplementary Figure S1B). Here, SREBF2 is linked to posterior cortical atrophy.